 |
|
Is Specimen Mammography Beneficial?
David N. Bimston, MD;
Gregory G. Bebb, MD;
Lawrence D. Wagman, MD
Arch Surg. 2000;135:1083-1086.
Hypothesis Specimen mammography is not beneficial in the management or outcome of patients undergoing image-guided needle-localized breast biopsies.
Design A retrospective study of consecutive patients who underwent needle/dye-localized breast biopsies between January 1, 1993, and December 31, 1995.
Setting National Cancer Institute (Bethesda, Md)–designated comprehensive cancer center.
Patients One hundred sixty-four patients underwent 165 needle/dye-localized breast biopsies for suspicious mammographic abnormalities.
Results In only 3 (1.8%) of 165 patients did the patient clearly benefit from specimen mammography. In no patient was a malignant neoplasm missed. The mean time for the specimen mammogram was 20 minutes, adding an additional 55 hours of operating room time. Specimen mammography cost an additional $60,522 and was incorrect in 41 (24.8%) of 165 patients.
Conclusion Specimen mammography added little to patient care, as only 3 (1.8%) of 165 patients benefited from the information.
From the Department of General Oncologic Surgery, City of Hope National Medical Center, Duarte, Calif.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Is Specimen Mammography Beneficial?—Invited Critique
Douglas Reintgen
Arch Surg. 2000;135(9):1089.
EXTRACT
| FULL TEXT
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(9):1121-1122.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sonography of postexcision specimens of nonpalpable breast lesions: value, limitations, and description of a method.
Mesurolle et al.
Am. J. Roentgenol. 2006;186:1014-1024.
ABSTRACT
| FULL TEXT
Potential Margin Distortion in Breast Tissue by Specimen Mammography
Clingan et al.
Arch Surg 2003;138:1371-1374.
ABSTRACT
| FULL TEXT
|
